Skip to content

Author

E. V. Fernandes

We have 4 of 45 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Effects of an 18-Week Workplace Gymnastics Program on Selected Components of Health-related Physical Fitness in Administrative Workers: A Non-Randomized Clinical Trial.

OBJECTIVES To evaluate the effects of an 18-week workplace gymnastics (WG) program on selected components of health-related physical fitness in administrative workers. METHODS This non-randomized study (n=66) compared low (LA, <35 sessions) and good adherence (GA, ≥35 sessions) groups across an 18-week program (15-mi...

Letícia Resende Viegas, D. D. de Oliveira, Letícia Mendes de Morais et al. · 0 citations
Open access Jan 2026

Endemic Persistence of Bovine Leukemia Virus in aHigh‐Producing Brazilian Dairy Herd: Seroprevalence Across Production Strata, Vertical Transmission, and Mortality Risk

The impact of this disease on the lifespan of the herd should not be underestimated, particularly when considering mortality rates, incidence, and vertical transmission, which underscore the progressive nature of the virus.

Karla Cristina Resplandes da Costa Paz, Leonardo Costa Paes, Dirceu Guilherme de Souza Ramos et al. · 0 citations
Open access Jul 2026

Dysregulation of the miR-34a/SIRT1 Regulatory Network Is Associated with Cardiometabolic Risk in Type 2 Diabetes

Cardiometabolic risk in T2DM is associated with a coordinated molecular signature characterized by miR-34a upregulation, SIRT1 suppression, systemic inflammation, oxidative stress, and endothelial dysfunction, suggesting that integrated biomarker profiling may complement conventional risk assessment and support future...

F. M. de Oliveira, F. S. Lizarte, E. V. Fernandes et al. · 0 citations
Jul 2026

Epigenetic Remodeling Through GSK343-induced EZH2 Inhibition Alters SMYD2/SMYD3 Expression and Promotes Antitumor Effects.

These findings demonstrate that EZH2 inhibition promotes coordinated epigenetic remodeling and disrupts key oncogenic pathways in breast cancer cells, and suggest potential combinatorial strategies integrating EZH2 inhibition with other targeted or epigenetic therapies to enhance treatment efficacy, overcome resistance...

Thaís Amanda Damasceno Silva, E. V. Fernandes, Mayara Bocchi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.